Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
302.00    -1.00 (-0.33%)
Bid:
305.00
Ask:
308.00
Spread: 3.00 (0.984%)
Market Cap: £271.46m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Acquisition of Croydex Group Ltd

25 Jun 2015 07:00

RNS Number : 1641R
Norcros PLC
25 June 2015
Β 

Β 

Β 

Β 

Β 

25 June 2015

Β 

Β 

("Norcros", the "Group" or the "Company")

Β 

Acquisition of Croydex Group Ltd

Β 

Norcros, the market leading supplier of innovative branded showers, taps, bathroom accessories, tiles and adhesives, is pleased to announce that it has completed the acquisition of 100% of the share capital of Croydex Group Ltd ("Croydex"), a privately-owned business held by the Brown and Marriott-Dodington families and Nick McGrellis for a total consideration of Β£21.9m, of which Β£20.8m has been settled in cash and Β£1.1m consideration deferred for three years. The acquisition has been funded entirely by debt through existing facilities. The Board expects the transaction to be earnings enhancing immediately.

Β 

Croydex - business

Β 

Croydex is a market-leading, innovative designer, manufacturer and distributor of high quality bathroom furnishings and accessories with strong customer relationships in both the UK trade and retail segments. The business benefits from a skilled in-house design team which creates new products, combining style and innovation, in collaboration with partners in the UK and overseas.

Β 

Croydex is based in Andover, Hampshire, with extensive purpose-built warehousing and on-site manufacturing facilities. The business employs 82 people and has an experienced management team led by Managing Director Nick McGrellis, all of whom will be staying with the business.

Β 

Further information on Croydex can be found at http://www.croydex.com.

Β 

Croydex - financial information

Β 

For the year ended 31 December 2014, Croydex's audited financial statements showed revenue of Β£19.9m, EBITDA before shareholder costs of Β£2.7m and profit before tax and shareholder costs of Β£2.6m. As at 31 December 2014 Croydex had gross assets of Β£13.7m. For the 12 months to 31 March 2015, the unaudited EBITDA before shareholders costs was Β£3.1m.

Β 

Acquisition details

Β 

Norcros has acquired 100% of the share capital of Croydex for an initial cash consideration of Β£20.8m plus deferred consideration of Β£1.1m payable in the year ending 31 March 2019. The consideration includes a payment of Β£1.9m for net cash balances and normalised working capital adjustments, such that on a debt free, cash free, normalised working capital basis, the consideration is Β£20.0m. This represents 6.5 times the unaudited EBITDA for the 12 months to 31 March 2015. The Group has incurred acquisition related costs of Β£0.8m as a result of the transaction.

Β 

In addition to this, a long term incentive scheme has been put in place for Managing Director Nick McGrellis which will pay up to Β£0.9m dependent on the financial performance of Croydex over the next three years. Costs associated with this incentive will be treated as an acquisition related cost outside of underlying operating profit.

Β 

Β 

Acquisition rationale

Β 

The acquisition of Croydex is an important next step in the Group's growth strategy to increase revenue to Β£420m by 2018 and follows on from the very successful integration of the Vado business which Norcros acquired in March 2013. Adding the Croydex business to our existing portfolio will increase the breadth of our product range in the bathroom segment and enables us to offer an even broader range of complementary bathroom products to our customers. The business will also benefit from the global distribution channels, sourcing skills and strong financial position of the enlarged Group.

Β 

Commenting on the acquisition, Nick Kelsall, Group Chief Executive, said "The acquisition of Croydex is a compelling fit with our strategic growth criteria, broadening the Group's product offer as well as providing a number of opportunities to drive revenue and procurement synergies. I have been impressed by the quality, energy and vision of the management team at Croydex and I look forward to working with them to further develop and grow the Croydex business."

Β 

Nick McGrellis, Managing Director of Croydex remarked, "This transaction marks a new chapter in the history of the Croydex business which dates back over 90 years. I am confident that being part of Norcros will enable us to accelerate the strong progress we have made over the last few years."

Β 

ENQUIRIES:

Β 

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Group Chief Executive

Β 

Martin Payne, Group Finance Director

Β 

Β 

Β 

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

Β 

Charlie Jack

Β 

Katie Matthews

Β 

Β 

Notes to Editors

Β· Norcros is a leading supplier of high quality and innovative showers, taps, bathroom accessories, ceramic wall and floor tiles and adhesive products with operations primarily in the UK and South Africa.

Β 

Β· Based in the UK, Norcros operates under four brands:

Β· Triton Showers - Market leader in the manufacture and marketing of showers in the UK

Β· Vado - A leading manufacturer and supplier of taps, mixer showers, bathroom accessories and valves

Β· Johnson Tiles - A leading manufacturer and supplier of ceramic tiles in the UK

Β· Norcros Adhesives - Manufacturer of tile and stone adhesives, grouts and related products

Β 

Β· Based in South Africa, Norcros operates under three brands:

Β· Tile Africa - Chain of retail stores focused on ceramic and porcelain tiles, and associated products such as sanitary ware, showers and adhesives

Β· Johnson Tiles South Africa - Manufacturer of ceramic and porcelain tiles

Β· TAL - The leading manufacturer of ceramic and building adhesives

Β 

Β· Norcros is headquartered in Wilmslow, Cheshire and employs around 1750 people. The Company is listed on the London Stock Exchange. For further information please visit the Company website: http://www.norcros.com/

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQSESSLIFISEDM
Date   Source Headline
11th Jun 20267:00 amRNSResults for the 53 weeks ended 5 April 2026
21st May 20267:00 amRNS-RInvestor Presentation Webinar on 18 June 2026
12th May 20267:00 amRNSStrategic update: South African operations
30th Apr 202611:42 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSYear-end Trading and Board update
2nd Apr 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSBlock Listing Six Monthly Return
3rd Mar 20269:29 amRNSDirectors Share Dealing - correction
3rd Mar 20267:00 amRNSDirectors Share Dealing
2nd Feb 20267:00 amRNSAppointment of Joint Corporate Broker
14th Jan 202612:12 pmRNSDirectors Share Dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
19th Dec 20253:52 pmRNSEmployee SAYE awards and director share dealing
28th Nov 20254:03 pmRNSHolding(s) in Company
20th Nov 20256:22 pmRNSDirectors Share Dealing
20th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNS-RInvestor Presentation Webinar on 1 December 2025
21st Oct 20255:04 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSTrading update
13th Oct 20257:24 amRNSCompletion of Acquisition of Fibo Holding AS
30th Sep 202511:46 amRNSBlock Listing Six Monthly Return
23rd Jul 202512:03 pmRNSDirector Dealings - APSP and DBP Share Options
23rd Jul 202511:59 amRNSResults of AGM
23rd Jul 20257:11 amRNSAGM Trading Statement
21st Jul 20254:11 pmRNSDirector Dealings - DBP Share Option exercises
16th Jul 20255:01 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSAcquisition of Fibo Holding AS
23rd Jun 20257:00 amRNSJTSA Outcome of Strategic Review
20th Jun 20254:10 pmRNSAnnual Financial Report and Notice of 2025 AGM
12th Jun 20257:00 amRNSResults for the year ended 31 March 2025
3rd Jun 20257:00 amRNS-RInvestor Webinar
10th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
31st Mar 20257:00 amRNSBlock Listing 6 Monthly Return
31st Mar 20257:00 amRNSTotal Voting Rights
13th Mar 20257:00 amRNSPension Scheme Valuation Update
5th Feb 20253:45 pmRNSDirectors Share Dealing
31st Dec 20247:00 amRNSVoting Rights and Share Capital Update
10th Dec 202411:49 amRNSHolding(s) in Company
6th Dec 202411:52 amRNSHolding(s) in Company
3rd Dec 20244:39 pmRNSTotal Voting Rights
21st Nov 20245:01 pmRNSHolding(s) in Company
21st Nov 202411:57 amRNSInterim Results - Replacement
21st Nov 20247:00 amRNSResults for the six months ended 30 September 2024
1st Nov 20247:00 amRNSTotal Voting Rights
10th Oct 20247:00 amRNSTrading update
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 202410:08 amRNSBlock listing Six Monthly Return
30th Aug 20247:00 amRNSTotal Voting Rights
24th Jul 20241:50 pmRNSResults of AGM
24th Jul 20241:24 pmRNSDirector Dealings - APSP Share Option Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.